We reported the efficacy of CAP in selectively arresting the growth of HCC cells via triggering autophagy and proposed the EGFR/p-JNK/BIRC6/LC3B molecule axis that drove this process. The gene discussed is EGFR; the disease is hepatocellular carcinoma.